Navigation Links
Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
Date:2/11/2008

the commercial introduction of

Zingo.

Adlea

-- Continued enrollment in two Phase 2 trials of Adlea for post-operative

pain associated with orthopedic surgeries: one in patients undergoing

total hip replacement surgery, and a second in patients undergoing knee

replacement surgery. These trials are investigating a higher dose of

Adlea that might provide increased efficacy. Anesiva previously

successfully studied a lower dose of Adlea in patients undergoing knee

replacement surgery.

-- Proceeded with plans to initiate Phase 3 trials of Adlea in

post-surgical pain associated with orthopedic surgeries, including one

trial in patients undergoing bunionectomy surgeries and one trial in

patients undergoing total knee replacement surgeries.

Corporate Developments

Anesiva announced that Richard P. Powers, vice president and chief financial officer, will resign at the end of the month to pursue other interests, while remaining a consultant to the company. He will be succeeded by Jean-Frederic Viret, Ph.D., who is currently Anesiva's vice president, finance.

"Dick has been a valuable member of the Anesiva senior management team, having served as chief financial officer and leader of successful financing efforts almost since the company's inception. We are grateful for his many contributions and will appreciate the ongoing benefit of his counsel," said Mr. McLaughlin. "We are also pleased that we will have a smooth transition with the promotion of Jean Viret to vice president and chief financial officer. Jean has been a leader in our finance group since 2002, and we are confident that in this new position he will have a significant role in Anesiva's growth."

Jean-Frederic Viret, Ph.D. joined Anesiva in 2002 and was promoted to vice president, finance in 2006. Prior to Anesiva, Jean was associate director of finance at Tularik Inc. (now Amg
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Anesiva Appoints Daniel Janney to Board of Directors
2. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
3. Anesiva Announces Completion of Common Stock Offering
4. Anesiva Raises $45 Million in Common Stock Offering
5. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
6. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
7. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
8. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
9. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... (PRWEB) September 19, 2014 ... its potential to revolutionize the world has attracted ... corporations and small start-ups. The early years of ... projects largely due to the high risks involved, ... budgets earmarked for this evolving technology have been ...
(Date:9/19/2014)... , Sept. 19, 2014 Pfenex Inc. (NYSE ... development of high-value and difficult to manufacture proteins including ... at the 21 st Annual NewsMakers in the ... . Bertrand Liang , chief executive officer of ... programs and business strategy on Friday, September 26, 2014 ...
(Date:9/19/2014)... Dublin ... announced the addition of the  "Micro Market Monitor ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... fastest-growing segments in the chromatography market. The market ... expected to reach $2.0 billion by 2019, at ...
(Date:9/18/2014)... TX (PRWEB) September 18, 2014 ... integrated urological and interventional radiology products and services, ... known as cryotherapy and cryoablation) versus external beam ... Section of the American Urological Association (MAAUA) Annual ... , "Comparing Relative Effectiveness of Cryosurgery and External ...
Breaking Biology Technology:Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Pfenex to Present at Upcoming Industry Conference on September 26 2Micro Market Monitor : Global Pre-packed Chromatography Columns 2HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2
... March 31 For the first time, scientists have ... embryo) may be a potential new source of stem ... on February 12, 2009, in Blood , the ... on observations made by other scientists, our research team ...
... GENEVA, Switzerland, March 31 Viroblock SA ... VCCD Tech antiviral nasal spray,formulation is active ... Technology (VCCD Tech) inactivates enveloped,viruses during the ... envelopes. , The ...
... "personal genomics," featuring five of the most outstanding scientists, physicians and ... Bio-IT World Conference & Expo being held April 27-29 at the ... ... (PRWEB) March 31, 2009 -- A plenary panel discussion on the ...
Cached Biology Technology:Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 2Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 3Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray 2Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 2Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 3Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 4Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 5
(Date:9/18/2014)... into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne ... similar to that caused by Ebolavirus, has identified new ... the potential to lead to novel targets for therapeutic ... reported in a paper published today in the journal ... the Texas Biomedical Research Institute and their colleagues, represents ...
(Date:9/18/2014)... matter how many times it,s demonstrated, it,s still ... , But by using a signaling system ... their behavior to suit their population. In short, ... present, and act accordingly. , Once the population ... change from innocuous to pathogenic, or from unhelpful ...
(Date:9/18/2014)... their colleagues have built the first smartphone app ... and behavioral trends. In other words, your smartphone ... you don,t -- and how that affects you. ... stress, depression and loneliness to their academic performance, ... for example, to monitor mental health, trigger ...
Breaking Biology News(10 mins):Research milestone in CCHF virus could help identify new treatments 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4
... the upcoming Acoustical Society of America (ASA) meeting in ... Wide pressroom even if they cannot attend in person. ... papers selected from among the 600 talks and posters, ... sound engineering, marine biology, medicine, meteorology, and music. ...
... ambitious European collaboration proposes to set up a new ... requisite skills for accelerating research into cardiovascular disease, the ... deaths, depending on the country. The European Vascular Biology ... conference in Lisbon in December 2007 with a specific ...
... for naming rights to a new owl butterfly species ... bid of $40,800, with proceeds benefiting continued research on ... George Austin and Andrew Warren discovered the new butterfly ... it in this weeks issue of the Bulletin of ...
Cached Biology News:Acoustics World Wide press room now open 2Acoustics World Wide press room now open 3Acoustics World Wide press room now open 4Proposal to step up cardiovascular disease research 2UF's new owl butterfly species naming rights auctioned for $40,800 2UF's new owl butterfly species naming rights auctioned for $40,800 3
... microplate stacker system, offers fast and reliable ... devices:, , Ultra Evolution , SAFIRE monochromator ... SpectraFluor Plus , LS Series of Laser ... a wide range of detection and separation ...
... your life easier. It offers a wide array of ... balance. *Instruments supported: ... XS, XP, PR, SR, PG-S, PG, SG, AT, MT, ... User guidance on the balance ...
... The STag Purification Kits enable rapid ... STag fusion proteins produced from appropriate vectors. ... up to 1 mg target protein under ... incubated with S-protein Agarose, which specifically retains ...
Request Info...
Biology Products: